Welcome to LookChem.com Sign In|Join Free

CAS

  • or

302963-97-9

Post Buying Request

302963-97-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

302963-97-9 Usage

Physical state

White solid

Structural components

+ Thiazole ring
+ Trifluoromethyl group
+ Carboxylic acid functional group
+ tert-Butoxycarbonyl protected amino group

Uses

Building block in organic synthesis and pharmaceutical research

Potential applications

Development of new drugs and materials

Unique features

Structure and reactivity

Check Digit Verification of cas no

The CAS Registry Mumber 302963-97-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,2,9,6 and 3 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 302963-97:
(8*3)+(7*0)+(6*2)+(5*9)+(4*6)+(3*3)+(2*9)+(1*7)=139
139 % 10 = 9
So 302963-97-9 is a valid CAS Registry Number.

302963-97-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-(trifluoromethyl)-1,3-thiazole-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2-tert-butoxycarbonyloxyamino-4-trifluoromethyl-thiazole-5-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:302963-97-9 SDS

302963-97-9Relevant articles and documents

THIAZOLE AND THIOPHENE COMPOUNDS

-

Page/Page column 23, (2012/09/25)

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, asthma and COPD

Cyclic protein tyrosine kinase inhibitors

-

Page 21, (2010/02/06)

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 302963-97-9